APA (7th ed.) Citation

Wechsler, M. E., Menzies-Gow, A., Brightting, C. E., Kuna, P., Korn, S., Welte, T., . . . Colice, G. (2022). Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): A randomised, placebo-controlled, phase 3 study. The lancet. Respiratory medicine, 10(7), . https://doi.org/10.1016/S2213-2600(21)00537-3

Chicago Style (17th ed.) Citation

Wechsler, Michael E., et al. "Evaluation of the Oral Corticosteroid-sparing Effect of Tezepelumab in Adults with Oral Corticosteroid-dependent Asthma (SOURCE): A Randomised, Placebo-controlled, Phase 3 Study." The Lancet. Respiratory Medicine 10, no. 7 (2022). https://doi.org/10.1016/S2213-2600(21)00537-3.

MLA (9th ed.) Citation

Wechsler, Michael E., et al. "Evaluation of the Oral Corticosteroid-sparing Effect of Tezepelumab in Adults with Oral Corticosteroid-dependent Asthma (SOURCE): A Randomised, Placebo-controlled, Phase 3 Study." The Lancet. Respiratory Medicine, vol. 10, no. 7, 2022, https://doi.org/10.1016/S2213-2600(21)00537-3.